Verastem Oncology to Participate in Upcoming November Investor Conferences
Business Wire•02/11/2026•07:30 ET
0
Key Highlights
- ➤Verastem management to present at three November healthcare investor conferences
- ➤Guggenheim conference presentation scheduled November 9 in Boston
- ➤Wolfe Research conference presentation scheduled November 10 in New York City
- ➤Jefferies London conference presentation scheduled November 16 in London
- ➤Verastem markets AVMAPKI FAKZYNJA CO-PACK in the U.S.
Verastem Oncology to Participate in Upcoming November Investor Conferences
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team is scheduled to present at the following investor conferences:
Get started
Create a free account to read the full story.